Cytori- Its Technology

Cytori- Its Technology (6)

 

The Technology section of the page, contains articles that describes the technology "made by Cytori".

It briefly touches a general topic of the future of regenerative medicine regarding the combination of biomaterials and cells, before the virtues of ADRCs are discussed in respect to stem- and regenerative cells from other adult sources. The IP position is explained, which is extremely strong and the result of it all - the development of the safe and superior cell extraction devices- extracting clinical grade regenerative cells from adipose tissue- the Celution family of devices.

Wednesday, 01 February 2012 10:50

Cytori- The Basic science of ADRCs

Written by
The basic science of Cytori- Properties of ADRC´s versus other cell sources This comes straight from the Cytori homepage: Science & Technology Cytori Therapeutics’ goal is to provide access to clinical grade Adipose-Derived Stem and Regenerative Cells (ADRCs). ADRCs, sometimes referred to as stromal vascular fraction cells, are a heterogeneous or mixed population of cells found in adipose tissue. This…
Last modified on Monday, 22 February 2016 05:08
Friday, 03 February 2012 15:48

Mechanisms of Therapeutic Action of ADRCs

Written by
In the Wall Street press one always reads, when the theme "stem cells" comes up, what the difference in adult- and embryonic cell differentiation potential is and what these magic things all can do, or what they cant do. Words like pluripotency, multipotency and sometimes even the word progenitor cell come up and are the buzz words, in providing an…
Last modified on Monday, 22 February 2016 05:06
Saturday, 04 February 2012 16:34

The versatility of the Celution Extraction Device

Written by
There seem to be several misconceptions or maybe just different opinions about the ability for Cytori to protect the IP, which went into the designing- and engineering of the Celution range of products. Thereto different opinions about the technical superiority of the same system. I do not think the following write-up will eliminate differences of opinion, but provides sufficient additional…
Last modified on Monday, 22 February 2016 05:05
Sunday, 21 February 2016 14:52

Half a Can of Coke

Written by
Half a can of coke of fat tissue extracted from the subcuteneous part of the belly, is the standard introduction by all presenters of Cytori managers at Investor conferences over the past eight years, when they start describing what amount of fat is needed from a patient before that fat is processed by Celution to extract a therapeutic dose of…

Media

Last modified on Monday, 22 February 2016 05:02
Thursday, 02 February 2012 11:50

Cytori´s Intellectual Property Position

Written by
Build-up of Cytori´s Intellectual Property rights Especially with an emerging- and most likely disruptive technology, the protection of one´s IP is of prime importance. Obviously there are several ways to protect the business- secrecy- and privacy- for instance are also part of that, which is one of the reasons why I am doing this Investor HP- there is more to…
Last modified on Monday, 22 February 2016 05:07
Wednesday, 08 February 2012 18:00

Cytori´s Platform Applications

Written by
  Cytori´s immensely large technology platform The versatility of ADRC´s in general provides a gigantic opportunity for Cytori as a first mover in this space, to collect the low hanging fruit and establish themselves before others do so, whilst being protected by an impressive IP portfolio in the mean time. As a general rule of thumb, what has crystalized out…
Last modified on Wednesday, 24 February 2016 09:51

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites